MedTrace Logo

Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic

NCT04451798 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-11-01

No results posted yet for this study

Summary

Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device

Conditions

  • Cardiogenic Shock

Interventions

DEVICE

Impella CP microaxial pump

ramp test

Sponsors & Collaborators

  • Jena University Hospital

    collaborator OTHER

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Sven Möbius-Winkler, MD · Universityhospital Jena

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
91 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-12-31
Completion
2023-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04451798 on ClinicalTrials.gov